To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Clinical trial NCT07684820 · RECRUITING

Trial details

NCT number: NCT07684820
Sponsor: Expedition Therapeutics, Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2026-06-30
Primary completion: 2028-06-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.